Unexplained fetal death, pre-eclampsia and fetal growth restriction in pregnancy: Who is screened for antiphospholipid syndrome?

Antiphospholipid syndrome (APS) is defined by thrombosis or pregnancy morbidity associated with persistent antiphospholipid autoantibodies (aPL) namely, lupus anticoagulant (LA) and/or IgG/IgM anticardiolipin antibodies (aCL) and/or IgG/IgM anti- β2glycoprotein-1 (aβ2GPI) [1].

Source: Thrombosis Research - May 24, 2023 Category: Hematology Authors: Clothilde Gros, Tiphaine Barral, Arthur Mageau, Pascale Roland Nicaise, Val érie Vivier, Thomas Papo, Agnès Bourgeois-Moine, Tiphaine Goulenok, Karim Sacre Tags: Letter to the Editors-in-Chief Source Type: research